What Researchers Did
Researchers described two diabetic female patients with severe mucormycosis who were treated with topical hydrogen peroxide after standard antifungal therapy failed.
What They Found
Both patients, who had rhinoorbital or sphenoid sinus mucormycosis and were not improving with intravenous Amphotericin B, saw their fungal infections apparently eradicated with 1/2 strength topical hydrogen peroxide soaks. The authors suggest that hydrogen peroxide destroys the fungus and supporting host tissue through oxidation.
What This Means for Canadian Patients
For Canadian patients with mucormycosis, especially those who do not respond to standard treatments like Amphotericin B, this case report suggests that topical hydrogen peroxide could be a potential additional therapy. This approach might offer an alternative for severe fungal infections that are difficult to treat.
Canadian Relevance
This study is not Canadian and does not involve Canadian authors. Mucormycosis is not a Health Canada-recognized indication for hyperbaric oxygen therapy.
Study Limitations
As a case report involving only two patients, this study's findings may not apply broadly to all mucormycosis cases and lack a control group for comparison.